NfL blood levels may help predict long-term progression of MS, Elevated nerve damage markers found even with no acute relapses
4.7
$ 12.00
In stock
(438)
Product Description
The clinical perspective: How to personalise treatment in MS and how may biomarkers including imaging contribute to this? - Patrick Vermersch, Thomas Berger, Ralf Gold, Carsten Lukas, Alex Rovira, Bianca Meesen, Declan
High or increasing serum NfL is predictive of impending multiple sclerosis relapses - ScienceDirect
Neurofilament Light Chain in the Blood As Biochemical Markers in the Critically Ill
NfL Blood Test May Help Predict MS Disease Activity, Treatment Response
Biomedicines, Free Full-Text
Molecular models of multiple sclerosis severity identify heterogeneity of pathogenic mechanisms
NfL predicts relapse-free progression in a longitudinal multiple sclerosis cohort study - ScienceDirect
Serum neurofilament light chain predicts long term clinical outcomes in multiple sclerosis
In Relapsing MS, NfL Levels Help in Disease Progression Prediction
Neurofilament light levels are associated with long-term outcomes in multiple sclerosis - Jens Kuhle, Tatiana Plavina, Christian Barro, Giulio Disanto, Dipen Sangurdekar, Carol M Singh, Carl de Moor, Bob Engle, Bernd C
Frontiers Neurofilament Proteins as Biomarkers to Monitor Neurological Diseases and the Efficacy of Therapies
Neurofilament light chain level is a weak risk factor for the development of MS – topic of research paper in Clinical medicine. Download scholarly article PDF and read for free on CyberLeninka
NfL blood levels may help predict long-term progression of MS, Elevated nerve damage markers found even with no acute relapses
/cdn.vox-cdn.com/uploads/chorus_image/image/71467178/1430197236.0.jpg "TOTALLY NOT FAKE NEWS: Houston Texans…Let's Try This Again, Shall We? - Battle Red Blog")
